Anesthetic profile of dexmedetomidine identified by stimulus-response and continuous measurements in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 1, 1999, Pages 153-160

  Bol, Cornelis J J G ^a,d,e   Vogelaar, John P W ^b,d   Mandema, Jaap W ^c,d  

^a Janssen Pharmaceutica ^*  (Belgium)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c PHARSIGHT CORPORATION   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE;

ADRENERGIC RECEPTOR BLOCKING; ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD GAS; BLOOD PRESSURE MEASUREMENT; BRADYCARDIA; CARDIOVASCULAR EFFECT; CORNEA REFLEX; DRUG BLOOD LEVEL; DRUG EFFECT; ELECTROENCEPHALOGRAM; HYPNOSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RIGHTING REFLEX; SEDATION; STARTLE REFLEX; STEADY STATE; STIMULUS RESPONSE; TAIL FLICK TEST;

ANALGESICS, NON-NARCOTIC; ANIMALS; CARDIOVASCULAR SYSTEM; ELECTROENCEPHALOGRAPHY; HEART RATE; IMIDAZOLES; MALE; MEDETOMIDINE; PAIN MEASUREMENT; RATS; RATS, WISTAR;

EID: 0032842402     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Aho MS, Erkola OA, Scheinin H, Lehtinen A-M and Korttila KT (1991) Effect of intravenously administered dexmedetomidine on pain after laparoscopic tubal ligation. Anesth Analg 73:112-118.
2. Ausems ME, Hug CC, Stanski DR and Burm AG (1986) Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery. Anesthesiology 65:362-373.
3. Beal SL, Boeckmann AJ and Sheiner LB (1992) NONMEM User's Guide Part I-VI. NONMEM Project Group, University of California, San Francisco, San Francisco, CA.
4. Belleville JP, Ward DS, Bloor BC and Maze M (1992) Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation and metabolic rate. Anesthesiology 77:1125-1133.
5. Bol CJJG, Danhof M, Stanski DR and Mandema JW (1997a) Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses of iv dexmedetomidine in the rat. J Pharmacol Ther Exp 283:1051-1058.
6. 3H]-clonidine radioreceptor assay. J Pharm Sci 86:822-826.
7. Chiu T-H, Chen M-J, Yang Y-R, Yang J-J and Tang F-I (1995) Action of dexmedetomidine on rat locus coeruleus neurones: Intracellular recording in vitro. Eur J Pharmacol 285:261-268.
8. 2 agonist, is mediated in the locus coeruleus in rats. Anesthesiology 76:948-952.
9. DeBoer T and Tobler I (1995) Temperature dependence of EEG frequencies during natural hypothermia. Brain Res 670:153-156.
10. Dyck JB, Maze M, Haack C, Vuorilehto L and Shafer SL (1993) The pharmacokinetics and hemodynamic effects of iv and intramuscular dexmedetomidine hydrocholoride in adult human volunteers. Anesthesiology 78:813-820.
11. Ebling WF, Danhof M and Stanski DR (1991) Pharmacodynamic characterization of the electroencephalo-graphic effects of thiopental in rats. J Pharmacokinet Biopharm 19:123-143.
12. Gustafsson LL, Ebling WF, Osaki E and Stanski DR (1996) Quantitation of depth of thiopental anesthesia in the rat. Anesthesiology 84:415-427.
13. Hug CC (1990) Does opioid "anesthesia" exist? (Editorial). Anesthesiology 73:1-4.
14. Hung OR, Varvel JR, Shafer SL and Stanski DR (1992) Thiopental pharmacodynamics. II. Quantitation of clinical and electroencephalographic depth of anesthesia. Anesthesiology 77:237-244.
15. 2-adrenoceptor agonist-in healthy volunteers. Pain 46:281-285.
16. Janssen PAJ, Niemegeers CJE and Dony JGH (1963) The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex in rats. Arzneim Forsch 13:502-507.
17. Jorm CM and Stamford JA (1993) Actions of the hypnotic anaesthetic, dexmedetomidine, on noradrenaline release and cell firing in rat locus coeruleus slices. Br J Anaeshesia 71:447-449.
18. 2 adrenoceptor agonist, on experimental pain in humans. Anesthesiology 74:3-8.
19. Kissin I (1993) General anesthetic action: An obsolete notion? (Editorial). Anesth Analg 76:215-218.
20. Kivistö KT, Kallio A and Neuvonen PJ (1994) Pharmacokinetics and pharmacodynamics of transdermal dexmedetomidine. Eur J Clin Pharmacol 46:345-349.
21. Lemmens H (1995) Pharmacokinetic-pharmacodynamic relationships for opioids in balanced anaesthesia. Clin Pharmacokinet 29:231-242.
22. 2-adrenergic receptor subtypes b and c. Science (Wash DC) 273:803-805.
23. MacDonald E, Scheinin M, Scheinin H and Virtanen R (1991) Comparison of the behavioural and neurochemical effects of the two optical enantiomers of medetomidine, a selective alpha-2-adrenoceptor agonist. J Pharmacol Exp Ther 259:848-854.
24. Mandema JW and Danhof M (1990) Pharmacokinetic-pharmacodynamic modelling of the CNS effects of heptabarbital using aperiodic EEG analysis. J Pharmacokinet Biopharm 18:459-481.
25. Mandema JW and Danhof M (1992) Electroencephalogram effect measures and relationships between pharmacokinetics and pharmacodynamics of centrally acting drugs. Clin Pharmacokinet 23:191-215.
26. Mandema JW and Wada DR (1995) Pharmacodynamic model for acute tolerance development to the electroencephalographic effects of alfentanil in the rat. J Pharmacol Exp Ther 275:1185-1194.
27. Mizobe T and Maze M (1995) α2-Adrenoceptor agonists and anesthesia. Int Anesth Clin 33:81-102.
28. Peden CJ and Prys-Roberts C (1992) Dexmedetomidine: A powerful new adjunct to anaesthesia? (Editorial). Br J Anaeath 68:123-125.
29. Prys-Roberts C (1987) Anaesthesia: A practical or impossible construct? (Editorial). Br J Anaesth 59:1341-1345.
30. Roman RJ, Cowley AW and Lechene C (1979) Water diuretic and natriuretic effect of clonidine in the rat. J Pharmacol Ther Exp 211:385-393.
31. Scheinin M (1992) The locus coeruleus: Site of hypnotic actions of α2-adrenoceptor agonists? Anesthesiology 76:873-875.
32. Scheinin H, Karhuvaara S, Olkkola KT, Kallio A, Anttila M, Vuorilehto L and Scheinin M (1992) Pharmacodynamics and pharmacokinetics of intramuscular dexmedetomidine. Clin Pharmacol Ther 52:537-546.
33. Scott JC, Ponganis KV and Stanski DR (1985) EEG quantitation of narcotic effect: The comparative pharmacodynamics of fentanyl and alfentanil. Anesthesiology 62:234-241.
34. Seidel W, Maze M, Dement WC and Edgar DM (1995) Alpha-2 adrenergic modulation of sleep: Time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in rat. J Pharmacol Exp Ther 275:263-273.
35. Shafer SL and Gregg KM (1992) Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer-controlled infusion pump. J Pharmacokinet Biopharm 20:147-169.
36. Stanski DR (1990) Monitoring depth of anesthesia, in Anesthesia, 3rd ed (Miller R eds) pp 1001-1029, Churchill Livingstone, New York.
37. Stanski DR (1992) Pharmacodynamic measurement and modeling of anesthetic depth, in The In Vivo Study of Drug Action (Van Boxtel CJ, Holford NHG and Danhof M eds) pp 155-179, Elsevier Science Publishers BV, Amsterdam.
38. Thornton C and Gareth Jones J (1993) Evaluating depth of anesthesia: Review of methods. Int Anesth Clin 31:67-88.
39. van Zwieten PA (1988) Antihypertensive drugs interacting with α- and β-adrenoceptors: A review of basic pharmacology. Drugs 35:6-19.